(Q40637109)

English

The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro

scientific article published on 7 August 2003

Statements

The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro (English)
J M W Gee
M E Harper
I R Hutcheson
T A Madden
D Barrow
J M Knowlden
R A McClelland
N Jordan
A E Wakeling
R I Nicholson
7 August 2003
5105-5117

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit